How common is a lurbinectedin allergy?

How common are lurbinectedin allergies?

Reported hypersensitivity reactions to lurbinectedin remain uncommon in clinical use. Across the registration trial and post-marketing surveillance, grade 3 or higher allergic events occurred in less than 1 percent of patients, with most reactions limited to mild rash or infusion-site irritation.

What causes an allergic reaction to lurbinectedin?

Lurbinectedin is a synthetic alkaloid that can trigger immune responses either through direct mast-cell activation or through recognition of its carrier excipients. Reactions often appear during or shortly after the first few infusions, and patients with prior platinum exposure appear at modestly higher risk.

Can lurbinectedin cause anaphylaxis?

True anaphylaxis has been documented in isolated case reports but is rare enough that the prescribing information does not list it as a boxed warning. Immediate epinephrine, antihistamines, and corticosteroids remain the standard acute management when symptoms escalate.

How do doctors test for lurbinectedin allergy?

No validated skin test or laboratory assay exists. Diagnosis relies on clinical history and, when rechallenge is considered, a graded infusion protocol in a monitored setting. Desensitization protocols modeled on those used for other chemotherapeutic agents have been published for patients who need to continue therapy.

What should patients do if they had a reaction to lurbinectedin?

Any prior reaction warrants premedication with corticosteroids and antihistamines before subsequent doses. If symptoms recur despite premedication, permanent discontinuation or transition to an alternative regimen is usually advised.